The role of entrepreneurial decision-making in opportunity creation and recognition

Abstract This qualitative study investigates effectuation and causation as two opposing decisionmaking modes leading to opportunity creation and recognition. Prior literature posits that effectuation is linked to opportunity creation when the venture׳s future is highly uncertain and causation to opportunity recognition when the entrepreneur perceives risk rather than uncertainty. However, such a linear approach towards opportunity generation offers limited explanation as to how entrepreneurs decide to either create or search for entrepreneurial opportunities. This limitation becomes particularly apparent in the highly uncertain context of the biotechnology industry, where entrepreneurial decision-making processes iterate over long periods of time. To address this gap, we employ the embedded case study method to investigate 30 decisions made by three scientist-entrepreneurs commercializing platform biotechnology inventions. We inductively derive a model of entrepreneurial decision-making, which connects the environment to decision-making mode and opportunity generation. Our evidence reveals the iterative nature of opportunity generation and of decision-making modes as entrepreneurs respond to their evolving environment and to the level of regulatory and funding constraint, such that entrepreneurs can shift from effectuation to causation, remain in one particular mode, or adopt a combination mode. We also illustrate that effectuation does not always lead to opportunity creation.

[1]  V. Chiesa,et al.  Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis , 2011 .

[2]  P. Soh The role of networking alliances in information acquisition and its implications for new product performance , 2003 .

[3]  Waverly W. Ding,et al.  Divergent paths to commercial science: A comparison of scientists' founding and advising activities , 2011 .

[4]  Saras D. Sarasvathy,et al.  Knowing What to Do and Doing What You Know , 2005 .

[5]  Jay B. Barney,et al.  Discovery and creation: alternative theories of entrepreneurial action , 2007 .

[6]  William B. Gartner,et al.  A Conceptual Framework for Describing the Phenomenon of New Venture Creation , 1985 .

[7]  E. Garnsey,et al.  Commercializing Generic Technology: The Case of Advanced Materials Ventures , 2005 .

[8]  A. McGahan,et al.  Business-Model Innovation: General Purpose Technologies and their Implications for Industry Structure , 2010 .

[9]  H. Etzkowitz The norms of entrepreneurial science: cognitive effects of the new university-industry linkages , 1998 .

[10]  S. Sarasvathy Causation and Effectuation: Toward a Theoretical Shift from Economic Inevitability to Entrepreneurial Contingency , 2001 .

[11]  Gary P. Pisano,et al.  The Evolution of Science-Based Business: Innovating How We Innovate , 2010 .

[12]  Amalya L. Oliver,et al.  Social Networks, Learning, and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms , 1994 .

[13]  Annapoornima M. Subramanian,et al.  When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances , 2013 .

[14]  M. Fontes The process of transformation of scientific and technological knowledge into economic value conducted by biotechnology spin-offs , 2005 .

[15]  E. Garnsey,et al.  Process-based vs. product-based innovation: Value creation by nanotech ventures , 2012 .

[16]  Margarida Fontes,et al.  The commercialisation decisions of research-based spin-off: Targeting the market for technologies , 2012 .

[17]  J. DiMasi,et al.  Success rates for new drugs entering clinical testing in the United States , 1995, Clinical pharmacology and therapeutics.

[18]  Andy Neely,et al.  Inventors and Entrepreneurs in Academia: What Types of Skills and Experience Matter? , 2011 .

[19]  D. Shepherd Multilevel Entrepreneurship Research: Opportunities for Studying Entrepreneurial Decision Making , 2011 .

[20]  S. Shane,et al.  The Promise of Entrepreneurship as a Field of Research , 2000 .

[21]  Elizabeth Garnsey,et al.  Developmental conditions of UK biopharmaceutical ventures , 2003 .

[22]  W. Powell,et al.  Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .

[23]  Trudie Aberdeen Yin, R. K. (2009). Case study research: Design and methods (4th Ed.). Thousand Oaks, CA: Sage. , 2013, The Canadian Journal of Action Research.

[24]  G. Pisano Can science be a business? Lessons from biotech. , 2006, Harvard business review.

[25]  James M. Utterback,et al.  Radical Innovation from the Confluence of Technologies: Innovation Management Strategies for the Emerging Nanobiotechnology Industry , 2014 .

[26]  S. Shane A General Theory of Entrepreneurship , 2003 .

[27]  Todd R. Zenger,et al.  Opportunity Discovery, Problem Solving and a Theory of the Entrepreneurial Firm , 2007 .

[28]  Richard N. Cardozo,et al.  A theory of entrepreneurial opportunity identification and development , 2003 .

[29]  Stuart A Read,et al.  Effectual versus predictive logics in entrepreneurial decision-making: Differences between experts and novices , 2009 .

[30]  R. Yin Case Study Research: Design and Methods , 1984 .

[31]  Lowell W. Busenitz,et al.  Toward a Theory of Entrepreneurial Cognition: Rethinking the People Side of Entrepreneurship Research , 2002 .

[32]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[33]  J. Vernon,et al.  Financial risk of the Biotech Industry versus the Pharmaceutical Industry , 2009 .

[34]  Gerard George,et al.  Academics or entrepreneurs? Investigating role identity modification of university scientists involved in commercialization activity , 2009 .

[35]  P. Wong,et al.  Entrepreneurial Resource Acquisition through Indirect Ties: Compensatory Effects of Prior Knowledge , 2010 .

[36]  Rita Gunther McGrath Business Models: A Discovery Driven Approach , 2010 .

[37]  R. Yin,et al.  Case Study Research: Design and Methods (4th ed. , 2009 .

[38]  A. M. Subramanian,et al.  When do firms benefit from university–industry R&D collaborations? The implications of firm R&D focus on scientific research and technological recombination , 2014 .

[39]  H. Chesbrough Business Model Innovation: Opportunities and Barriers , 2010 .

[40]  Israel M. Kirzner Entrepreneurial Discovery and the Competitive Market Process: An Austrian Approach , 1997 .

[41]  David H. Hsu Experienced entrepreneurial founders, organizational capital, and venture capital funding , 2007 .

[42]  Nicholas Dew,et al.  What to Do Next? The Case for Non-Predictive Strategy , 2006 .

[43]  Kathleen M. Eisenhardt,et al.  Theory Building From Cases: Opportunities And Challenges , 2007 .

[44]  K. J. Samsom A longitudinal study of success and failure among scientist-started ventures , 2010 .

[45]  Salih Zeki Ozdemir,et al.  Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains , 2007 .

[46]  J. Niosi Alliances are not enough explaining rapid growth in biotechnology firms , 2003 .

[47]  R. Baron Opportunity Recognition as Pattern Recognition: How Entrepreneurs “Connect the Dots” to Identify New Business Opportunities , 2006 .

[48]  S. Shane Prior Knowledge and the Discovery of Entrepreneurial Opportunities , 2000 .

[49]  L. Willemstein,et al.  Dynamics in business models: An empirical analysis of medical biotechnology firms in the Netherlands , 2007 .

[50]  Troy V. Mumford,et al.  Causation and effectuation processes: A validation study , 2011 .

[51]  Jianzhen Xu,et al.  Connect the dots , 2013, Autophagy.

[52]  A. Bhide The Origin and Evolution of New Businesses , 2000 .

[53]  Nicholas Dew,et al.  New market creation through transformation , 2005 .

[54]  James C Greenwood,et al.  Biotechnology: Delivering on the Promise , 2010, Science Translational Medicine.

[55]  Jeffery S. McMullen,et al.  Entrepreneurial Action And The Role Of Uncertainty In The Theory Of The Entrepreneur , 2006 .

[56]  Elizabeth Garnsey,et al.  A Theory of the Early Growth of the Firm , 1998 .

[57]  Alice Lam,et al.  What motivates academic scientists to engage in research commercialization: ‘Gold’, ‘ribbon’ or ‘puzzle’? , 2011 .

[58]  Josep Samitier,et al.  Market challenges facing academic research in commercializing nano-enabled implantable devices for in-vivo biomedical analysis , 2012 .

[59]  Roberto Fontana,et al.  The Impact of Academic Patenting on University Research and Its Transfer , 2009 .

[60]  John T. Perry,et al.  Entrepreneurial Effectuation: A Review and Suggestions for Future Research , 2012 .